Read + Share
Amedeo Smart
Independent Medical Education
Demuth S, Bogdan T, Kremer L, Lanotte L, et al. Good therapeutic response to infliximab in a case of Susac syndrome refractory to immunotherapies including tocilizumab. J Neurol 2022;269:3347-3350.PMID: 35043222
Email
LinkedIn
Facebook
Twitter
Privacy Policy